查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1809677

药物输送系统市场（按输送系统类型、输送途径、治疗用途和最终用户）—2025-2030 年全球预测

Drug Delivery Systems Market by Delivery System Type, Delivery Route, Therapeutic Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计 2024 年药物输送系统市值将达到 442.2 亿美元，2025 年将成长至 475.2 亿美元，复合年增长率为 7.65%，到 2030 年将达到 688.4 亿美元。

主要市场统计数据
基准年2024年 442.2亿美元
预计2025年 475.2亿美元
预测年份 2030 688.4亿美元
复合年增长率（%） 7.65%

药物输送系统的演变以及改善患者治疗效果的创新治疗方案的需求

在过去的几十年里，药物输送系统经历了重大变革，其驱动力源于人们对疗效、病人安全性和治疗精准度的不懈追求。随着药物逐渐摆脱简单的散装製剂，对更精密输送系统的需求也日益增长。如今，药物输送系统的设计理念是，根据精确的时间和空间要求释放活性成分，从而最大限度地提高治疗效果，同时最大限度地减少全身副作用。

突破性技术和监管变化重塑全球医疗保健市场的药物传输生态系统

在技​​术突破和监管环境不断演变的共同推动下，药物传输领域正在经历深刻变化。连续生产平台逐渐摆脱传统的大量生产流程，开始精简生产流程，提高一致性与供应链弹性。同时，3D列印等增材製造技术正在为个人化给药和植入式设备释放新的可能性，从而能够根据每位患者的解剖结构和代谢情况提供个人化治疗方法。

2025年美国关税调整对药品配送供应链及跨国合作的影响

美国关税结构近期的调整，为依赖全球供应链的药品输送製造商带来了新的挑战。随着各种原料和成品进口关税的上调，企业面临成本上升的压力，不仅挤压了净利率，也迫使他们重新思考筹资策略。为此，一些公司正在加快近岸外包倡议，与国内供应商建立伙伴关係，并投资于本地製造能力，以降低跨境关税波动带来的风险。

根据输送系统类型、治疗应用途径和最终用户对关键细分市场进行深入研究，以製定市场策略

要深入了解市场动态，首先要考虑各种类型的给药系统，每种系统都针对不同的治疗目标量身定制。控制释放系统利用工程基质来调节活性分子的释放速率，进而延长药效。缓释性製剂旨在耐受胃部不适，保护敏感化合物直到到达肠道特定部位。相较之下，速释製剂则着重快速起效，这在急性照护中尤其重要。缓释性製剂平衡了初始给药和药物的缓慢释放，从而降低了给药频率。标靶递送平台使用配体或刺激响应载体，使其停留在特定组织中，从而提高药物的生物有效性并最大限度地减少偶然暴露。

战略区域视角重点关注美洲、欧洲、中东和非洲地区以及亚太地区的市场动态和驱动力

地理细分揭示了三个关键区域的不同机会和挑战：在美洲，强大的创新生态系统、大量的研发投资和优惠的报销制度正在推动先进交付技术的快速应用；成熟的生物製药丛集和强大的创业投资环境支持新型设备的开发和扩大规模；

对产业领导者及其推动药物输送解决方案创新和竞争优势的策略性倡议进行批判性分析

行业领导者正在寻求差异化发展路径，以在不断发展的药物传输领域中保持竞争优势。大型製药企业正在与专业设备製造商合作，共同开发从製剂到给药的一体化平台技术。同时，合约研发和受託製造公司正在拓展产能和技术力，以满足日益增长的生物製药产品线的外包需求。

为行业领导者提供可行的策略建议，以应对药物输送系统的新兴趋势并加强其市场定位

要在技术进步和贸易政策变化的背景下取得成功，产业领导者必须采取多管齐下的策略。投资整合人工智慧进行配方优化的研究，可以加快发现週期并降低开发风险。建立连接材料科学、数据分析和临床专业知识的跨职能团队，可以建立更具凝聚力的创新管道。

采用定性和定量技术的严谨调查方法，确保对药物传输市场的洞察的可靠性和深度

本报告基于严谨的研究框架，融合了定性和定量方法。二次研究包括对同行评审文献、监管文件、专利资料库、公司资讯披露和技术白皮书的广泛查阅。这项全面的案头研究使我们能够识别关键趋势、技术里程碑和竞争动态。

全面审视快速发展的药物输送产业格局，概述相关人员的关键要点和未来挑战

摘要：药物输送产业正处于关键的十字路口，其特点是技术创新日新月异、监管格局不断演变以及全球贸易动态瞬息万变。了解输送系统、途径、应用和最终用户细分的相关人员最有能力根据市场需求调整策略投资。此外，区域差异需要采取独特的方法，在应对复杂政策的同时，充分利用区域优势。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

  • 微针贴片技术在无痛疫苗和胰岛素注射的应用日益广泛
  • 标靶奈米粒子载体在癌症治疗药物位点特异性的应用进展
  • 增加口服薄膜製剂的使用以提高中枢神经系统药物的生物有效性
  • 响应生理刺激的智慧型药物传输平台的出现
  • 扩展 3D 列印植入设备用于标靶治疗药物输送
  • 透过整合可穿戴生物感测器和经皮吸收贴片实现个人化药物监测
  • 标靶抗体药物复合体的出现，助力精准癌症治疗
  • 扩展长效注射剂技术，实现精神科药物的持续释放
  • 口腔薄膜条可提高患者的依从性并促进药物在黏膜上的快速吸收
  • 刺激响应型智慧聚合物的兴起，可在慢性病管理中实现按需释放药物

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 药物输送系统市场（依输送系统类型）

  • 控释系统
  • 延迟释放系统
  • 即时释放系统
  • 缓释系统
  • 标靶递送系统

9. 药物传输系统市场（依输送途径）

  • 颊部/舌下给药
  • 吸入给药
  • 注射药物输送
    • 自动注射器
    • 长效注射
    • 预填充式注射器
  • 鼻腔内给药
  • 眼科药物输送
  • 口服给药
    • 胶囊
    • 暂停
    • 糖浆
    • 药片
  • 直肠/阴道给药
  • 经经皮给药
    • 凝胶
    • 修补

10. 药物传输系统市场（依治疗应用）

  • 自体免疫疾病
  • 心血管疾病
  • 中枢神经系统疾病
  • 胃肠道疾病
  • 荷尔蒙失调
  • 感染疾病
  • 肿瘤学
  • 疼痛管理
  • 呼吸系统疾病

第 11 章药物传输系统市场（依最终使用者）

  • 门诊治疗中心
  • 居家照护环境
  • 医院和诊所

12.美洲药物传输系统市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

13. 欧洲、中东和非洲药物传输系统市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

14.亚太药物传输系统市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十五章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • AptarGroup, Inc.
    • AstraZeneca Plc
    • Boston Scientific Corporation
    • Cospheric LLC
    • DelSiTech Ltd.
    • Enable Injections, Inc.
    • F. Hoffmann-La Roche AG
    • Insulet Corporation
    • Johnson & Johnson Service, Inc.
    • Lonza Group Ltd.
    • Merck KGaA
    • Merit Medical Systems, Inc.
    • Novartis AG
    • Pacira BioSciences, Inc.
    • Pfizer Inc.
    • Polysciences Inc.
    • Sanofi SA
    • SHL Medical
    • Societal CDMO by CoreRx, Inc.
    • Terumo Corporation
    • Thermo Fisher Scientific Inc.
    • West Pharmaceutical Services, Inc.

第十六章 研究人工智慧

第十七章 研究统计

第十八章 研究联络人

第十九章 研究报导

第二十章 附录

Product Code: MRR-CA7E340319CB

The Drug Delivery Systems Market was valued at USD 44.22 billion in 2024 and is projected to grow to USD 47.52 billion in 2025, with a CAGR of 7.65%, reaching USD 68.84 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 44.22 billion
Estimated Year [2025] USD 47.52 billion
Forecast Year [2030] USD 68.84 billion
CAGR (%) 7.65%

The Evolution of Drug Delivery Systems and the Imperative for Innovative Therapeutic Solutions to Advance Patient Outcomes

Over the past several decades, drug delivery systems have undergone a profound transformation, driven by an unwavering pursuit of enhanced efficacy, patient safety, and therapeutic precision. As pharmaceuticals move beyond simple bulk formulations, the need for more sophisticated vehicles has intensified. Today's landscape is defined by technologies engineered to release active ingredients according to precise temporal and spatial requirements, minimizing systemic side effects while maximizing therapeutic outcomes.

Moreover, the maturation of materials science has introduced polymers, lipids, and novel biomaterials that respond to biological triggers, enabling tailored release profiles that were once the realm of science fiction. Concurrent advances in microfabrication and nanotechnology have allowed for devices small enough to traverse cellular barriers or adhere to mucosal surfaces, providing localized delivery in ways that standard oral or injectable forms cannot replicate.

In tandem with these technical breakthroughs, there is an increasing emphasis on patient-centricity. Ease of administration, dose frequency reduction, and device ergonomics now play central roles in development, reflecting a shift from purely clinical performance metrics toward a holistic view of therapy management. As a result, stakeholders across research, manufacturing, and clinical practice are recognizing that the next frontier of drug delivery innovation hinges on integrating smart materials, digital health interfaces, and advanced manufacturing methodologies.

Breakthrough Technological and Regulatory Transformations That Are Reshaping the Drug Delivery Ecosystem Across Global Healthcare Markets

The drug delivery landscape is undergoing a seismic shift fueled by a confluence of technological breakthroughs and evolving regulatory frameworks. Transitioning from traditional batch processes, continuous manufacturing platforms have started to streamline production, offering enhanced consistency and supply chain resilience. At the same time, additive manufacturing techniques, such as 3D printing, are unlocking new possibilities in personalized dosing and implantable devices, ensuring that therapies can be tailored to individual patient anatomies and metabolic profiles.

Furthermore, the convergence of artificial intelligence and machine learning with formulation science is accelerating the discovery of optimized drug-carrier pairs. Predictive modeling now guides material selection and release kinetics design, reducing development timelines and resource expenditure. Alongside these R&D innovations, regulators are adapting policies to accommodate novel modalities, with accelerated pathways and harmonized guidelines emerging across major markets. These progressive frameworks underscore an industry-wide commitment to balancing rigorous safety assessments with expeditious access to transformative treatments.

Consequently, stakeholders must navigate an environment where technology adoption and regulatory agility intersect. Companies that proactively engage with evolving standards, invest in digital infrastructure, and collaborate closely with health authorities will be poised to lead the next wave of drug delivery innovation.

How United States Tariff Adjustments in 2025 Are Poised to Influence Drug Delivery Supply Chains and Cross-Border Collaborations

Recent adjustments to United States tariff structures have introduced new complexities for drug delivery manufacturers that rely on global supply chains. As import duties rise on various raw materials and finished components, companies face escalating costs that can erode margins and compel reconsideration of sourcing strategies. In response, some firms are accelerating near-shoring initiatives, by cultivating partnerships with domestic suppliers and investing in local production capacity to mitigate exposure to cross-border tariff fluctuations.

Moreover, the tariff environment has instigated a reevaluation of collaborative agreements between international entities. Joint ventures and licensing arrangements are now being structured to redistribute financial risk, while R&D hubs are emerging in tariff-favored jurisdictions, ensuring that innovation pipelines remain robust despite geopolitical pressures. At the same time, logistical networks are being optimized through multi-modal transport planning and inventory decentralization, reducing the impact of any single trade barrier.

Ultimately, the interplay of tariff policy and supply chain strategy will continue to influence drug delivery economics in 2025 and beyond. Organizations that adopt flexible procurement models, engage in proactive policy monitoring, and leverage cross-border alliances will be better equipped to sustain competitive positioning in an increasingly protectionist trade environment.

Detailed Examination of Key Segments Based on Delivery System Type Route Therapeutic Application and End User to Inform Market Strategies

A nuanced understanding of market dynamics begins with an examination of delivery system types, each tailored to distinct therapeutic objectives. Controlled release systems utilize engineered matrices to modulate the release rate of active molecules, extending efficacy over prolonged durations. Delayed release formats are designed to resist gastric conditions, protecting sensitive compounds until they reach specific intestinal regions. Immediate release formulations, by contrast, prioritize rapid onset of action, especially critical in acute care scenarios. Sustained release approaches balance initial dosing with gradual liberation of medication, reducing the frequency of administration. Targeted delivery platforms employ ligands or stimulus-responsive carriers that home in on specific tissues, improving drug bioavailability while minimizing collateral exposure.

Beyond system type, delivery route selection profoundly impacts treatment adherence and patient experience. Buccal and sublingual administration bypass first-pass metabolism for faster systemic uptake. Inhalation methods deliver aerosols directly to the pulmonary system, crucial for respiratory disorders. Injectable modalities, including autoinjectors, depot injections, and prefilled syringes, afford precise dosing and are pivotal in chronic conditions requiring consistent therapeutic levels. Nasal and ocular routes open pathways to localized treatment, avoiding systemic dilution. Oral formulations, from capsules to tablets, syrups, and suspensions, remain widespread due to user familiarity, whereas transdermal gels and patches offer continuous, noninvasive delivery.

Therapeutic application further defines market priorities. Oncology treatments increasingly leverage targeted carriers to deliver cytotoxic agents directly to tumor sites. Autoimmune and hormonal disorder therapies benefit from sustained release mechanisms that stabilize plasma concentrations. In infectious disease management and pain control, immediate release and injectable formats are indispensable. Central nervous system and cardiovascular indications, as well as gastrointestinal and respiratory disorders, each demand customized solutions to navigate physiological barriers and enhance pharmacokinetic profiles.

Finally, end user settings shape product requirements. Ambulatory care centers require portable, easy-to-administer devices that facilitate outpatient procedures, while hospitals and clinics demand high-precision delivery systems that integrate with clinical workflows. Home care environments call for simplified interfaces and self-administration support, empowering patients to manage long-term therapies autonomously.

Strategic Regional Perspectives Highlighting Distinct Dynamics and Growth Drivers Across the Americas EMEA and Asia-Pacific Markets

Geographic segmentation reveals divergent opportunities and challenges across three principal regions. In the Americas, a robust innovation ecosystem, significant R&D investment, and favorable reimbursement frameworks foster rapid adoption of advanced delivery technologies. Established biopharmaceutical clusters and a strong venture capital environment support novel device development and scale-up.

In Europe, the Middle East, and Africa, regulatory harmonization within the European Union contrasts with emerging hubs in the Middle East, where healthcare infrastructure modernization drives demand for innovative therapies. Meanwhile, Africa's growing network of clinical trial sites and expanding public health initiatives are elevating access to drug delivery solutions, albeit gradually.

The Asia-Pacific region is characterized by its expansive manufacturing capacity and diverse regulatory landscapes. Rapidly aging populations and rising incidence of chronic diseases constitute a significant demand driver. Government-led initiatives to incentivize local production and streamline approvals have spurred investments in both multinational facilities and homegrown enterprises, making Asia-Pacific a pivotal arena for cost-effective innovation.

Critical Analysis of Leading Industry Players and Their Strategic Initiatives Driving Innovation and Competitive Advantage in Drug Delivery Solutions

Leading industry participants are charting differentiated paths to maintain competitive advantage in the evolving drug delivery arena. Large pharmaceutical corporations are forging alliances with specialized device manufacturers to co-develop integrated platform technologies that span formulation through administration. Simultaneously, contract development and manufacturing organizations are expanding capacity and technical capabilities to capture outsourcing demand driven by biopharma's pipeline growth.

Several device-focused innovators are securing intellectual property around responsive materials and digital connectivity, positioning themselves as critical enablers of next-generation therapies. These companies often pursue strategic acquisitions to bolster their technology portfolios, while investing heavily in clinical collaborations to validate performance in therapeutic contexts. Moreover, emerging players are leveraging open innovation models, engaging academia and startup accelerators to access disruptive ideas and rapidly translate them into scalable solutions.

Collectively, these strategic maneuvers underscore the importance of collaboration, intellectual property stewardship, and targeted R&D investment. Organizations that align their innovation roadmaps with unmet clinical needs and regulatory trends will capture outsized benefits in the competitive ecosystem.

Actionable Strategic Recommendations for Industry Leaders to Navigate Emerging Trends and Enhance Market Positioning in Drug Delivery Systems

To thrive amid technological advances and shifting trade policies, industry leaders must adopt multifaceted strategies. Investing in research that integrates artificial intelligence for formulation optimization can accelerate discovery cycles and reduce development risk. Establishing cross-functional teams that bridge materials science, data analytics, and clinical expertise will foster more cohesive innovation pipelines.

Simultaneously, firms should diversify supply chains by developing regional manufacturing hubs and forging partnerships with both domestic and global suppliers. This approach not only mitigates tariff exposure but also enhances responsiveness to local market needs. Early engagement with regulatory authorities in target jurisdictions will streamline approval pathways, while participation in pre-competitive consortia can shape standards and harmonize guidelines.

Furthermore, advancing patient-centric design through human factors engineering and digital interfaces will differentiate product offerings. By incorporating wearables and connected platforms, companies can gather real-time adherence data, inform post-market surveillance, and deliver value-added services. Finally, embedding sustainability principles into material selection and process design will meet growing stakeholder expectations and future-proof operations.

Rigorous Research Methodology Employing Qualitative and Quantitative Techniques to Ensure Reliability and Depth of Drug Delivery Market Insights

The foundation of this report lies in a rigorous research framework that synthesizes qualitative and quantitative methodologies. Secondary research encompassed an extensive review of peer-reviewed literature, regulatory filings, patent databases, company disclosures, and technical white papers. This comprehensive desk research enabled identification of key trends, technological milestones, and competitive dynamics.

Primary research involved structured interviews with senior executives, R&D specialists, regulatory affairs professionals, and clinical practitioners. These engagements provided first-hand perspectives on innovation drivers, unmet needs, and market entry considerations. Insights were further validated through roundtable discussions with advisory board members representing diverse stakeholder groups.

To ensure data reliability, findings from disparate sources were triangulated through cross-referencing company-reported metrics with third-party analyses and expert opinions. Advanced analytical tools were employed to detect emerging patterns and project qualitative implications. Furthermore, a peer review process was instituted to verify methodological integrity, ensuring that conclusions are grounded in robust evidence and reflect the latest industry developments.

Consolidated Reflections Summarizing Key Takeaways and Future Imperatives for Stakeholders in the Rapidly Evolving Drug Delivery Industry Landscape

In summary, the drug delivery industry stands at a pivotal juncture characterized by rapid technological innovation, evolving regulatory landscapes, and changing global trade dynamics. Stakeholders who understand the nuanced segmentation of delivery systems, routes, applications, and end users will be best positioned to align their strategic investments with market needs. Moreover, regional variations underscore the necessity for tailored approaches that leverage local strengths while navigating policy complexities.

Leaders who incorporate actionable recommendations-ranging from AI-driven formulation development and supply chain diversification to patient-centric design and sustainability integration-will capture growth opportunities and mitigate emerging risks. The strategic initiatives of leading companies demonstrate that collaboration, intellectual property protection, and targeted R&D remain foundational to competitive advantage.

As the industry continues to evolve, decision-makers must remain agile, engaging with regulatory authorities, forging cross-border alliances, and prioritizing innovation that places patients at the center. By doing so, they will not only address current market imperatives but also pave the way for transformative therapies that redefine standards of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Growing adoption of microneedle patch technology for pain-free vaccine and insulin delivery
  • 5.2. Advancements in targeted nanoparticle carriers for site-specific cancer drug delivery
  • 5.3. Increasing use of oral thin film formulations to enhance bioavailability of CNS medications
  • 5.4. Emergence of smart drug delivery platforms responsive to physiological stimuli
  • 5.5. Expansion of 3D printed implantable devices tailored for targeted therapeutic release
  • 5.6. Integration of wearable biosensors with transdermal patches for personalized drug monitoring
  • 5.7. Emergence of targeted antibody-drug conjugates for precise cancer therapy delivery
  • 5.8. Expansion of long-acting injectable depot technologies for sustained psychiatric medication release
  • 5.9. Increase in oral thin film strips enhancing patient compliance and rapid mucosal drug absorption
  • 5.10. Rise in stimuli-responsive smart polymers enabling on-demand drug release in chronic disease management

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Drug Delivery Systems Market, by Delivery System Type

  • 8.1. Introduction
  • 8.2. Controlled Release Systems
  • 8.3. Delayed Release Systems
  • 8.4. Immediate Release Systems
  • 8.5. Sustained Release Systems
  • 8.6. Targeted Delivery Systems

9. Drug Delivery Systems Market, by Delivery Route

  • 9.1. Introduction
  • 9.2. Buccal/Sublingual Drug Delivery
  • 9.3. Inhalation Drug Delivery
  • 9.4. Injectable Drug Delivery
    • 9.4.1. Autoinjectors
    • 9.4.2. Depot Injections
    • 9.4.3. Prefilled Syringes
  • 9.5. Nasal Drug Delivery
  • 9.6. Ocular Drug Delivery
  • 9.7. Oral Drug Delivery
    • 9.7.1. Capsules
    • 9.7.2. Suspensions
    • 9.7.3. Syrups
    • 9.7.4. Tablets
  • 9.8. Rectal/Vaginal Drug Delivery
  • 9.9. Transdermal Drug Delivery
    • 9.9.1. Gels
    • 9.9.2. Patches

10. Drug Delivery Systems Market, by Therapeutic Application

  • 10.1. Introduction
  • 10.2. Autoimmune Diseases
  • 10.3. Cardiovascular Diseases
  • 10.4. Central Nervous System Disorders
  • 10.5. Gastrointestinal Disorders
  • 10.6. Hormonal Disorders
  • 10.7. Infectious Diseases
  • 10.8. Oncology
  • 10.9. Pain Management
  • 10.10. Respiratory Diseases

11. Drug Delivery Systems Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Home Care Settings
  • 11.4. Hospitals & Clinics

12. Americas Drug Delivery Systems Market

  • 12.1. Introduction
  • 12.2. United States
  • 12.3. Canada
  • 12.4. Mexico
  • 12.5. Brazil
  • 12.6. Argentina

13. Europe, Middle East & Africa Drug Delivery Systems Market

  • 13.1. Introduction
  • 13.2. United Kingdom
  • 13.3. Germany
  • 13.4. France
  • 13.5. Russia
  • 13.6. Italy
  • 13.7. Spain
  • 13.8. United Arab Emirates
  • 13.9. Saudi Arabia
  • 13.10. South Africa
  • 13.11. Denmark
  • 13.12. Netherlands
  • 13.13. Qatar
  • 13.14. Finland
  • 13.15. Sweden
  • 13.16. Nigeria
  • 13.17. Egypt
  • 13.18. Turkey
  • 13.19. Israel
  • 13.20. Norway
  • 13.21. Poland
  • 13.22. Switzerland

14. Asia-Pacific Drug Delivery Systems Market

  • 14.1. Introduction
  • 14.2. China
  • 14.3. India
  • 14.4. Japan
  • 14.5. Australia
  • 14.6. South Korea
  • 14.7. Indonesia
  • 14.8. Thailand
  • 14.9. Philippines
  • 14.10. Malaysia
  • 14.11. Singapore
  • 14.12. Vietnam
  • 14.13. Taiwan

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Abbott Laboratories
    • 15.3.2. AptarGroup, Inc.
    • 15.3.3. AstraZeneca Plc
    • 15.3.4. Boston Scientific Corporation
    • 15.3.5. Cospheric LLC
    • 15.3.6. DelSiTech Ltd.
    • 15.3.7. Enable Injections, Inc.
    • 15.3.8. F. Hoffmann-La Roche AG
    • 15.3.9. Insulet Corporation
    • 15.3.10. Johnson & Johnson Service, Inc.
    • 15.3.11. Lonza Group Ltd.
    • 15.3.12. Merck KGaA
    • 15.3.13. Merit Medical Systems, Inc.
    • 15.3.14. Novartis AG
    • 15.3.15. Pacira BioSciences, Inc.
    • 15.3.16. Pfizer Inc.
    • 15.3.17. Polysciences Inc.
    • 15.3.18. Sanofi S.A.
    • 15.3.19. SHL Medical
    • 15.3.20. Societal CDMO by CoreRx, Inc.
    • 15.3.21. Terumo Corporation
    • 15.3.22. Thermo Fisher Scientific Inc.
    • 15.3.23. West Pharmaceutical Services, Inc.

16. ResearchAI

17. ResearchStatistics

18. ResearchContacts

19. ResearchArticles

20. Appendix

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 14. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 16. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 22. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 23. DRUG DELIVERY SYSTEMS MARKET: RESEARCHAI
  • FIGURE 24. DRUG DELIVERY SYSTEMS MARKET: RESEARCHSTATISTICS
  • FIGURE 25. DRUG DELIVERY SYSTEMS MARKET: RESEARCHCONTACTS
  • FIGURE 26. DRUG DELIVERY SYSTEMS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELAYED RELEASE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELAYED RELEASE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUCCAL/SUBLINGUAL DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY BUCCAL/SUBLINGUAL DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOT INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DEPOT INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RECTAL/VAGINAL DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RECTAL/VAGINAL DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PATCHES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 92. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 93. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 94. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 95. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 96. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 97. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 98. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 99. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 100. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 101. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 102. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 103. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 104. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 105. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 107. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 108. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 109. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 110. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 111. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 112. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 113. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 114. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 115. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 116. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 117. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 119. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 121. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 122. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 123. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 124. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 125. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 126. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 127. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 128. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 129. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 130. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 131. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 132. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 133. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 134. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 135. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 137. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 140. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 141. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 142. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 143. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 144. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 145. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 146. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 147. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 151. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 154. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 155. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 156. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 157. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 158. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 159. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 160. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 161. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 165. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 167. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 168. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 169. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 170. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 171. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 172. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 173. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 174. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 175. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 176. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 177. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 198. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 199. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 200. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 201. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 202. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 203. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 204. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 205. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 211. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 212. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 213. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 215. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 217. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 219. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 221. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 222. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 223. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 226. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 227. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 228. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 229. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 230. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 231. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 232. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 233. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 237. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 239. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 240. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 241. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 242. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 243. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 244. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 245. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 246. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 247. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 249. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 251. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 254. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 255. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 256. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 257. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 258. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 259. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 260. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 261. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 262. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 263. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 265. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 267. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 268. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 269. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 270. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 271. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 272. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 273. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 274. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 275. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 276. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 277. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 278. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 287. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 288. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 289. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 295. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 296. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 297. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 298. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 299. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 300. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 301. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 302. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, 2025-2030 (USD MILLION)
  • TABLE 303. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 305. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 306. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 307. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY SYSTEM TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2018-2024 (USD MILLION)
  • TABLE 310. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY ROUTE, 2025-2030 (USD MILLION)
  • TABLE 311. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTABLE DRUG DELIVERY, 2018-2024 (USD MILLION)
  • TABLE 312. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY IN